These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 2473127

  • 1. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids.
    Schleimer RP, Derse CP, Friedman B, Gillis S, Plaut M, Lichtenstein LM, MacGlashan DW.
    J Immunol; 1989 Aug 15; 143(4):1310-7. PubMed ID: 2473127
    [Abstract] [Full Text] [Related]

  • 2. IFN-alpha inhibits IL-3 priming of human basophil cytokine secretion but not leukotriene C4 and histamine release.
    Chen YH, Bieneman AP, Creticos PS, Chichester KL, Schroeder JT.
    J Allergy Clin Immunol; 2003 Nov 15; 112(5):944-50. PubMed ID: 14610485
    [Abstract] [Full Text] [Related]

  • 3. IL-3 augments adhesiveness for endothelium and CD11b expression in human basophils but not neutrophils.
    Bochner BS, McKelvey AA, Sterbinsky SA, Hildreth JE, Derse CP, Klunk DA, Lichtenstein LM, Schleimer RP.
    J Immunol; 1990 Sep 15; 145(6):1832-7. PubMed ID: 1697310
    [Abstract] [Full Text] [Related]

  • 4. The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation.
    Kurimoto Y, De Weck AL, Dahinden CA.
    Eur J Immunol; 1991 Feb 15; 21(2):361-8. PubMed ID: 1705512
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action.
    Schleimer RP, MacGlashan DW, Gillespie E, Lichtenstein LM.
    J Immunol; 1982 Oct 15; 129(4):1632-6. PubMed ID: 6180017
    [Abstract] [Full Text] [Related]

  • 6. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
    Brunner T, de Weck AL, Dahinden CA.
    J Immunol; 1991 Jul 01; 147(1):237-42. PubMed ID: 1711077
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family.
    Kuna P, Reddigari SR, Schall TJ, Rucinski D, Sadick M, Kaplan AP.
    J Immunol; 1993 Mar 01; 150(5):1932-43. PubMed ID: 7679699
    [Abstract] [Full Text] [Related]

  • 8. IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein.
    Sarmiento EU, Espiritu BR, Gleich GJ, Thomas LL.
    J Immunol; 1995 Aug 15; 155(4):2211-21. PubMed ID: 7543541
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
    MacGlashan DW, Peters SP, Warner J, Lichtenstein LM.
    J Immunol; 1986 Mar 15; 136(6):2231-9. PubMed ID: 2419427
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human basophil releasability. III. Genetic control of human basophil releasability.
    Marone G, Poto S, Celestino D, Bonini S.
    J Immunol; 1986 Dec 01; 137(11):3588-92. PubMed ID: 2431036
    [Abstract] [Full Text] [Related]

  • 14. Glucocorticoids inhibit cytokine-mediated eosinophil survival.
    Wallen N, Kita H, Weiler D, Gleich GJ.
    J Immunol; 1991 Nov 15; 147(10):3490-5. PubMed ID: 1940348
    [Abstract] [Full Text] [Related]

  • 15. The in vitro and in vivo effect of corticosteroids on basophil releasability in patients with mild and severe bronchial asthma.
    Kivity S, Onn A, Agami O, Fireman E.
    Clin Exp Allergy; 1997 Aug 15; 27(8):909-14. PubMed ID: 9291288
    [Abstract] [Full Text] [Related]

  • 16. IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3.
    Kuna P, Reddigari SR, Kornfeld D, Kaplan AP.
    J Immunol; 1991 Sep 15; 147(6):1920-4. PubMed ID: 1716285
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative effect of recombinant IL-1, -2, -3, -4, and -6, IFN-gamma, granulocyte-macrophage-colony-stimulating factor, tumor necrosis factor-alpha, and histamine-releasing factors on the secretion of histamine from basophils.
    Alam R, Welter JB, Forsythe PA, Lett-Brown MA, Grant JA.
    J Immunol; 1989 May 15; 142(10):3431-5. PubMed ID: 2469713
    [Abstract] [Full Text] [Related]

  • 19. Altered surface expression of CD11 and Leu 8 during human basophil degranulation.
    Bochner BS, Sterbinsky SA.
    J Immunol; 1991 Apr 01; 146(7):2367-73. PubMed ID: 1706397
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.